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Development of helper T cell subsets: 
a central role for interleukin 12 
T he immune response pattern elicited during an infection depends on the type of 
causative agent. Humoral immun-
ity restricts the harmful effects of 
extracellular microorganisms and 
soluble toxins, while a cell-medi-
ated immune response controls the 
spread of intracellular pathogens. 
Generation of the appropriate im-
mune effector mechanisms is regu-
lated by the pattern of cytokines 
released by CD4+ helper T (T H) 
cells. They can be classified into 
two subsets: T H 1 cells give rise to 
cell-mediated immunity and are 
characterized by the production of 
interleukin 2 (IL-2) and gamma-
interferon (IFN-y), whereas T H2 
cells are more efficient in mediat-
ing antibody formation and secrete 
IL-4, IL-5, IL-6 and IL-lO (Refs 
1,2). 
Depending on the stage and the 
site of infection as weil as the 
genetic background of the host, 
pathogens trigger polarized T H 
responses3• Many bacteria, proto-
zoa and viruses stimulate T H 1 
cells, whereas helminths preferen-
tially induce T H2 cells. In murine 
models of malaria and schisto-
somiasis, consecutive activation 
of CD4+ T cell subsets has been 
observed; and in experimental 
leishmaniasis, mice of resistant 
strains develop a T H 1 response, 
whereas susceptible mice display 
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a T H2-like cytokine secretion 
pattern. 
Because the type of T H response 
induced may determine the out-
come of an infection, by favoring 
either control of the pathogen or 
promotion of disease, understand-
ing the mechanisms that direct the 
differentiation of T cell subsets is 
of considerable importance. There 
are several alternative, although 
not necessarily mutually exclusive, 
possibilities. 
First, different types of antigen-
presenting cells (macrophages, B 
cells or dendritic cells), delivering 
distinct co-stimulatory signals, may 
favor the expression of different 
sets of cytokines. In agreement 
with this hypothesis, it has been 
suggested that macrophages are 
required for generation of T H 1 
cells, whereas antigen presentation 
by B cells induces T H2-like cells4 • 
Second, the features of the anti-
gen may have a deterministic 
role. In experimentalleishmaniasis, 
studies with T H 1 or T H2 cell lines 
that have either a protective or 
an exacerbative effect, respectively, 
have shown that they respond 
to different pools of parasite 
antigens5• 
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Third, differences in the density 
of the T cell receptor ligand on the 
antigen-presenting cell surface may 
affect the type of developing T H 
ce1l6• 
Finally, Iymphokines themselves 
may regulate the pattern of Iym-
phokines produced by antigen-
stimulated CD4+ T cells. The pres-
ence of IL-4 or IL-10 prornotes 
the development of T H2 cells or in-
hibits T H1 formation, respectively, 
whereas IFN-y enhances the gen-
eration of T H 1 cells and suppresses 
proliferation of T H2 cells7- 9• Thus, 
T H 1 cells and T H2 cells crossregu-
late each other by self-stimulation 
and/or mutual inhibition, thereby 
creating a reciprocal relationship. 
However, what is the origin of 
such signals during primary T cell 
activation in the early phase of the 
host's interaction with a pathogen? 
Recently, a study by Hsieh et 
al. lo has shed light on these pro-
cesses. To examine antigen-depen-
dent priming and short-term dif-
ferentiation of T cells, the authors 
used an in vitra system in wh ich 
uniformly naive CD4+ T cells are 
derived from a transgenie mouse 
line that expresses only a T cell 
receptor specific for ovalbumin. 
The presence of Listeria mono-
cytogenes during in vitra priming 
with ovalbumin induced the devel-
opment of T H 1 cells, as character-
ized by secretion of IFN-y. This 
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effect on T cells involved an inter-
action between Listeria and macro-
phages that resulted in production 
of IL-12. Thus, IL-12 appears to 
act directly on naive CD4+ T cells 
to promote T H 1 development and 
initiation of cell-mediated immun-
ity. It therefore represents the 
counterpart of IL-4, which directly 
induces the generation of T H2 cells. 
In the presence of both IL-4 and 
IL-12, however, IL-4 was shown 
to be dominant because it decreased 
the level of IL-12-stimulated IFN-y 
production10. 
In addition, IL-12 seems to be 
important for the development of 
natural immunity. In mice with the 
severe combined immunodeficiency 
(SCID) mutation, which lack T 
and B cells, Listeria-stimulated IL-
12 induces IFN-y pro duc ti on by 
natural killer (NK) cellsll . IL-2 
acts synergistically with IL-12 to 
augment IFN-y release by NK cells 
as weIl as CD4+ T cells11,!2. On the 
other hand, tumor necrosis factor 
a (TNF-a) is required as a cofactor 
for the effect of IL-12 on NK cells 
but not on naive T cells10,1l. Thus, 
IL-12-dependent activation of NK 
cells and T cells may be regulated 
differently. 
Interestingly, the inhibitory ef-
fect of IL-1 0 on T H 1 developmene 
may be explained by its ability to 
block IL-12 production10. Because 
both cytokines are produced by 
macrophages, the commitment of 
CD4 + cells towards the T H 1lineage 
appears to be regulated by both 
inhibitory and stimulatory cyto-
kines released by innate immune 
cells before the development of 
specific immunity. 
It is conceivable that certain 
pathogens or host factors may 
favor the production of IL-12, 
resulting in preferential develop-
ment of T H 1 cells and induction of 
cell-mediated immunity rather than 
a humoral immune response. In 
murine cutaneous leishmaniasis, 
genetically resistant mice were 
found to have a greater capacity 
for IL-12 release than genetically 
susceptible mice13 • However, in 
the initial phase of infection (2 d), 
both resistant and susceptible mice 
produced significant levels of IL-
12 (Ref. 14). This is in accord with 
the above suggestion that the type 
of developing T H cell is also influ-
enced by the presence of inhibitory 
factors in the microenvironment. 
Probably the most important 
implication of the findings of Hsieh 
et al. is the possibility of using 
IL-12 for designing immunothera-
peutic agents or vaccines against 
infectious diseases. Towards this 
goal, encouraging results have been 
obtained in the experimental Leish-
mania mode[!3,15. Administration 
of IL-12 during the first week of 
infection with Leishmania major 
resulted in the cure of normally 
susceptible mice and provided re-
sistance against reinfection. These 
protective effects were associ-
ated with an increase in antigen-
stimulated IFN-y release and a 
markedly decreased production of 
IL-4, i.e. areversal ofTH1 and TH2 
activities. 
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